KG Jebsen B-cell malignancies

The Centre represents a multidisciplinary integration of life science research with preclinical development as well as clinical trials in B-cell malignancies

[Fredrik Schjesvold @MyelomaOslo]

A review of the new European myeloma guidelines.
https://t.co/0XnK4Q5Sqp

[Fredrik Schjesvold @MyelomaOslo]

https://t.co/WLUSUoAA5r

[Fredrik Schjesvold @MyelomaOslo]

Suksess med ny behandling for myelomatose.
https://t.co/oAbh50sJ4i

[Fredrik Schjesvold @MyelomaOslo]

Can we hope that CAR-T will be approved for Norwegian patients in 2021? https://t.co/GrdUb24fB2

[KG Jebsen B-cell malignancies @kg_cell]

Two of our KG Jebsen PIs (Munthe and Tjønnfjord) were part of the team who discovered the mechanisms behind the very rare but life-threatening condition after ChAdOx1 nCoV-19 Vaccination | NEJM https://t.co/ysp62UlrHR @stiftkgj

[Thea Kristin Våtsveen @TheaVatsveen]

https://t.co/IP4asHi7XC Come to Teknisk museum on thursday to visit our Cellfie-stand! Fun for the whole family and free of charge 18-20 @LabMyklebust @kg_cell

[Myklebust Lab @LabMyklebust]

Outstanding talk by our former PhD student Chloe Steen at ASH today!! She is now successful postdoc in the Alizadeh lab at Stanford!@UniOslo_MED @kg_cell

[KG Jebsen B-cell malignancies @kg_cell]

Great interest for the results from the clinical phase III study, testing efficacy of anti-CD38 antibody Isatuximab with Pomalidomide and Dexamethasone in Multiple Myeloma, presented by Fredrik Schjesvold (our KG Jebsen centre/Oslo Myeloma centre)
@MyelomaOslo @UniOslo_MED

[Myklebust Lab @LabMyklebust]

Amazing talk by Baoyan Bay at ASH today, presenting our data on tumor genome evolution in follicular lymphoma

[Myklebust Lab @LabMyklebust]

Kathrine is doing a great job, presenting the DLBCL90 Gene expresssion assay for predicting double hit lymphoma at ASH

[Myklebust Lab @LabMyklebust]

Great interest for Jillians work, focused on immune escape and mutational dynamics in Diffuse large B cell lymphoma

[KG Jebsen B-cell malignancies @kg_cell]

Ph.D. student Johanne Vestbøstad from our Jebsen center was awarded "Best Poster Presentation" at the Norwegian Society of Immunology Annual meeting. Congratulations!!
@OusResearch @stiftkgj

[KG Jebsen B-cell malignancies @kg_cell]

Cake celebration as Peter Huszthy and Ramakrishna Gopalakrishnan et al receive news that their paper has been accepted in PNAS (B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells). Congratulations!

[Myklebust Lab @LabMyklebust]

Excited for Jillian’s @jillianmcwise Nature News @NatureNV on 2,520 WGS metastatic cancer sites, a great effort by @ecuppen and collegues. https://t.co/3AxBq0etZe

[KG Jebsen B-cell malignancies @kg_cell]

Big congratulations to Fredrik Schjesvold who received funding from the Norwegian Cancer Society today! The clinical study, called REMNANT, is designed to determine if early detection and treatment of relapse will improve the prognosis for multiple myeloma patients. @stiftkgj

[KG Jebsen B-cell malignancies @kg_cell]

The Jebsen foundation treated participants at the Annual meting to music from Ole Bull and Edvard Grieg at Ole Bulls Home from 1860 at Lysøen outside Bergen. Fantastic music and architecture.

[KG Jebsen B-cell malignancies @kg_cell]

June, Fredrik and Ludvig are at the KG Jebsen stiftelsen Annual Retreat in the beautiful Solstrand Hotel. This is also the 10 year anniversary of the foundation. Topics: Patient and public involvement, GDPR, clinical trials, personalized medicine.

[Myklebust Lab @LabMyklebust]

Great science and great fun at the KG Jebsen Center for B-cell malignancies Annual Retreat

[Kjetil Tasken @KjetilTasken]

Great talks and great fun at KG Jebsen Ctr for B cell malignancies, @kg_cell, retreat and SAB visit. @Oslounivsykehus @MyelomaOslo @UniOslo_MED @TaskenLab @LabMyklebust #PrecisionMedicine @Blodkreft_Nor @Lymfekrforening @stiftkgj

[Myklebust Lab @LabMyklebust]

Collecting beautiful Hyperion images